REPRO MED SYSTEMS INC (REPR) earnings
Quarterly and annual REPR reports and results, each read against the price at its own news timestamp. Back to the REPR overview →
No REPR earnings events in the measured window.
Nothing matched in the current window — the REPR overview has every event we measure for this name.
Get an email when REPR moves on news →Keep exploring
More REPR: analyst actions → · SEC filings → · REPR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Community Health Systems, Inc. (CYH) | 379 | -0.16% | 42% |
| Albireo Pharma, Inc. (ALBO) | 378 | +0.05% | 53% |
| Akebia Therapeutics, Inc. (AKBA) | 377 | 0.00% | 49% |
| Amneal Pharmaceuticals, Inc. - Class A (AMRX) | 377 | -0.08% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.